Skip to content

Law firm helps deliver funding injection to healthcare company

LAW firm Ward Hadaway has advised on an investment in a Teesside healthcare specialist.

Corporate finance experts from the Newcastle office of Ward Hadaway provided legal advice to Rivers Capital Partners on the investment from the Finance for Business North East Fund in Acculabs Diagnostics.

Acculabs operates from offices and laboratories in Wynyard and Brighton and is one of the UK’s leading private providers of pathology services, such as testing and screening services.

The funding will enable the company to pursue its growth and job creation plans over the next few years.

Imogen Holland, Partner in the Corporate Finance department at Ward Hadaway in Newcastle, led the firm’s team advising Rivers Capital Partners on the transaction.

Imogen said: “We are delighted to have played our part in the investment into what is a cutting edge business in the North East.

“We have advised Rivers Capital Partners on a range of investments in companies across the region and it is always rewarding to see how the funding helps to promote innovation and enterprise in the North East.”

Ward Hadaway advised Rivers Capital Partners on over 20 investments from the Finance for Business North East Angel Fund last year alone.

Companies which received backing included a social network for motorcyclists, an explosives manufacturer and a flavoured coffee bean producer.

Please note that this briefing is designed to be informative, not advisory and represents our understanding of English law and practice as at the date indicated. We would always recommend that you should seek specific guidance on any particular legal issue.

This page may contain links that direct you to third party websites. We have no control over and are not responsible for the content, use by you or availability of those third party websites, for any products or services you buy through those sites or for the treatment of any personal information you provide to the third party.

Follow us on LinkedIn

Keep up to date with all the latest updates and insights from our expert team

Take me there

What we're thinking